Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
DEXYCU (dexamethasone intraocular suspension) 9%.
Locations
22
United States
Eye Center South Locations
Dothan, Alabama, United States
Inland Eye Specialists
Hemet, California, United States
Harvard Eye Associates
Laguna Hills, California, United States
Coastal Vision Medical Group
Orange, California, United States
North Bay Eye Associates, Inc.
Rohnert Park, California, United States
The Eye Associates of Manatee, LLP
Bradenton, Florida, United States
Start Date
November 13, 2019
Primary Completion Date
May 1, 2020
Completion Date
May 1, 2020
Last Updated
May 26, 2021
NCT07452770
NCT06979752
NCT07362043
NCT06060041
NCT07325188
NCT07305987
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions